Cargando…
High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care
Objective: Despite a wealth of treatment options for irritable bowel syndrome (IBS), data on the subjective experience of treatments in ongoing clinical practice are sparse. This follow-up study assessed the individual usage of treatment modalities by IBS patients over time and investigated the pati...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797829/ https://www.ncbi.nlm.nih.gov/pubmed/31681031 http://dx.doi.org/10.3389/fpsyt.2019.00714 |
_version_ | 1783459921077993472 |
---|---|
author | Dong, Yuanjun Baumeister, David Berens, Sabrina Eich, Wolfgang Tesarz, Jonas |
author_facet | Dong, Yuanjun Baumeister, David Berens, Sabrina Eich, Wolfgang Tesarz, Jonas |
author_sort | Dong, Yuanjun |
collection | PubMed |
description | Objective: Despite a wealth of treatment options for irritable bowel syndrome (IBS), data on the subjective experience of treatments in ongoing clinical practice are sparse. This follow-up study assessed the individual usage of treatment modalities by IBS patients over time and investigated the patients’ subjective experience of therapeutic impact. Methods: The study was conducted at the Specialty Clinic for Functional Gastrointestinal Disorders of the Heidelberg University Hospital. All patients who fulfilled the Rome III criteria for IBS and treated in our outpatient clinic between January 2012 and December 2016 were invited to the assessment. The primary outcome variables were individual usage of treatment modalities and the Patient Global Impression of Change (PGIC) with treatments. Results: Three hundred and sixty-six patients fulfilled the Rome III criteria for IBS and thus were eligible for this study. Two hundred and seven patients dropped out from the study. The study could include 159 patients (43.7 ± 17.1 years; 71.1% female). The mean time since the first visit to the clinic was 2.8 ± 1.3 years (median 3.0 years). The mean time of symptom duration was 14.1 ± 11.1 years (median 10 years). The average number of treatment attempts was 12, ranging from 2 to 39). With respect to the subjective experience of therapeutic impact, there were no significant differences in the PGIC scores among different treatments (p = 0.183). The rates of non-response rates (minimally improved, no change, or minimally worse) ranged from 63.0% to 83.9%. The PGIC score was correlated negatively with the mean number of treatment attempts (r = −0.316, p < 0.01). The mean number of treatment attempts was correlated negatively with quality of life (r = −0.262, p < 0.01). Conclusion: A multidisciplinary treatment approach of IBS is characterized by high rates of non-response and a high number of frustrating treatment attempts. The connection between the various treatment attempts and the frustrating subjective experience of therapeutic impact puts a substantial burden on IBS patients. |
format | Online Article Text |
id | pubmed-6797829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67978292019-11-01 High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care Dong, Yuanjun Baumeister, David Berens, Sabrina Eich, Wolfgang Tesarz, Jonas Front Psychiatry Psychiatry Objective: Despite a wealth of treatment options for irritable bowel syndrome (IBS), data on the subjective experience of treatments in ongoing clinical practice are sparse. This follow-up study assessed the individual usage of treatment modalities by IBS patients over time and investigated the patients’ subjective experience of therapeutic impact. Methods: The study was conducted at the Specialty Clinic for Functional Gastrointestinal Disorders of the Heidelberg University Hospital. All patients who fulfilled the Rome III criteria for IBS and treated in our outpatient clinic between January 2012 and December 2016 were invited to the assessment. The primary outcome variables were individual usage of treatment modalities and the Patient Global Impression of Change (PGIC) with treatments. Results: Three hundred and sixty-six patients fulfilled the Rome III criteria for IBS and thus were eligible for this study. Two hundred and seven patients dropped out from the study. The study could include 159 patients (43.7 ± 17.1 years; 71.1% female). The mean time since the first visit to the clinic was 2.8 ± 1.3 years (median 3.0 years). The mean time of symptom duration was 14.1 ± 11.1 years (median 10 years). The average number of treatment attempts was 12, ranging from 2 to 39). With respect to the subjective experience of therapeutic impact, there were no significant differences in the PGIC scores among different treatments (p = 0.183). The rates of non-response rates (minimally improved, no change, or minimally worse) ranged from 63.0% to 83.9%. The PGIC score was correlated negatively with the mean number of treatment attempts (r = −0.316, p < 0.01). The mean number of treatment attempts was correlated negatively with quality of life (r = −0.262, p < 0.01). Conclusion: A multidisciplinary treatment approach of IBS is characterized by high rates of non-response and a high number of frustrating treatment attempts. The connection between the various treatment attempts and the frustrating subjective experience of therapeutic impact puts a substantial burden on IBS patients. Frontiers Media S.A. 2019-10-02 /pmc/articles/PMC6797829/ /pubmed/31681031 http://dx.doi.org/10.3389/fpsyt.2019.00714 Text en Copyright © 2019 Dong, Baumeister, Berens, Eich and Tesarz http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Dong, Yuanjun Baumeister, David Berens, Sabrina Eich, Wolfgang Tesarz, Jonas High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care |
title | High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care |
title_full | High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care |
title_fullStr | High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care |
title_full_unstemmed | High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care |
title_short | High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care |
title_sort | high rates of non-response across treatment attempts in chronic irritable bowel syndrome: results from a follow-up study in tertiary care |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797829/ https://www.ncbi.nlm.nih.gov/pubmed/31681031 http://dx.doi.org/10.3389/fpsyt.2019.00714 |
work_keys_str_mv | AT dongyuanjun highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare AT baumeisterdavid highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare AT berenssabrina highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare AT eichwolfgang highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare AT tesarzjonas highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare |